Cargando…
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers
OBJECTIVES: To describe CSF‐defined neuronal intermediate filament (NIF) autoimmunity. METHODS: NIF‐IgG CSF‐positive patients (41, 0.03% of 118599 tested, 1996–2019) were included (serum was neither sensitive nor specific). Criteria‐based patient NIF‐IgG staining of brain and myenteric NIFs was dete...
Autores principales: | McKeon, Andrew, Shelly, Shahar, Zivelonghi, Cecilia, Basal, Eati, Dubey, Divyanshu, Flanagan, Eoin, Madhavan, Ajay A., Mariotto, Sara, Toledano, Michel, Tracy, Jennifer A., Zekeridou, Anastasia, Pittock, Sean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886032/ https://www.ncbi.nlm.nih.gov/pubmed/33369283 http://dx.doi.org/10.1002/acn3.51284 |
Ejemplares similares
-
Paraneoplastic neuronal intermediate filament autoimmunity
por: Basal, Eati, et al.
Publicado: (2018) -
Elevated LGI1‐IgG CSF index predicts worse neurological outcome
por: Gadoth, Avi, et al.
Publicado: (2018) -
Clinical spectrum of high-titre GAD65 antibodies
por: Budhram, Adrian, et al.
Publicado: (2021) -
Autoimmune Encephalitis Criteria in Clinical Practice
por: Orozco, Emma, et al.
Publicado: (2023) -
Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes
por: Shelly, Shahar, et al.
Publicado: (2021)